Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guerin (BCG) as a prevention against TB. BCG protects against disseminated disease...

Полное описание

Библиографические подробности
Главные авторы:	Hopkins, R, Bridgeman, A, Joseph, J, Gilbert, S, McShane, H, Hanke, T
Формат:	Journal article
Язык:	English
Опубликовано:	Public Library of Science 2011

Схожие документы

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
по: Richard Hopkins, и др.
Опубликовано: (2011-01-01)

Vaccine strategies against tuberculosis
по: H McShane
Опубликовано: (2009-03-01)

Vaccines for tuberculosis
по: McShane, H
Опубликовано: (2013)

Vaccine Platform for Prevention of Mother-to-Child Transmission of HIV-1 through Breastfeeding
по: Im, E, и др.
Опубликовано: (2008)

Insights and challenges in tuberculosis vaccine development
по: McShane, H
Опубликовано: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
по: McShane, H
Опубликовано: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
по: McShane, H
Опубликовано: (2011)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
по: Christopher J. De Voss, и др.
Опубликовано: (2025-02-01)

Vaccination against tuberculosis: how can we better BCG?
по: Pitt, J, и др.
Опубликовано: (2013)

Vaccination against tuberculosis: How can we better BCG?
по: Pitt, J, и др.
Опубликовано: (2013)

Tuberculosis vaccines: Progress and challenges
по: Checkley, A, и др.
Опубликовано: (2011)

Vaccine strategies against tuberculosis.
по: Mcshane, H
Опубликовано: (2009)

Developing an improved vaccine against tuberculosis.
по: Mcshane, H
Опубликовано: (2004)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
по: McShane, H
Опубликовано: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
по: Davenne, T, и др.
Опубликовано: (2016)

Clinical testing of tuberculosis vaccine candidates
по: Hatherill, M, и др.
Опубликовано: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
по: Vermaak, S, и др.
Опубликовано: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
по: Tanner, R, и др.
Опубликовано: (2016)

WHO preferred product characteristics for new vaccines against tuberculosis
по: Schrager, L, и др.
Опубликовано: (2018)

Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
по: Im, E, и др.
Опубликовано: (2007)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
по: Dockrell, HM, и др.
Опубликовано: (2022)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
по: Griffiths, K, и др.
Опубликовано: (2013)

Construction and characterization of recombinant MTBVAC. HIV, a new live attenuated vaccine against HIV and tuberculosis
по: Saubi, N, и др.
Опубликовано: (2018)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
по: Hazel M. Dockrell, и др.
Опубликовано: (2022-05-01)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
по: Villarreal-Ramos, B, и др.
Опубликовано: (2017)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
по: Sander, C, и др.
Опубликовано: (2007)

Human and Bovine Tuberculosis
по: McShane, H
Опубликовано: (2016)

MTBVAC-based TB-HIV vaccine is safe, elicits HIV-T cell responses, and protects against Mycobacterium tuberculosis in Mice
по: Broset, E, и др.
Опубликовано: (2019)

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine.
по: Bridgeman, A, и др.
Опубликовано: (2009)

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
по: Esther Broset, и др.
Опубликовано: (2019-06-01)

Identification of antigens presented by MHC for vaccines against tuberculosis
по: Bettencourt, P, и др.
Опубликовано: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
по: Bettencourt, P, и др.
Опубликовано: (2020)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
по: Stylianou, E, и др.
Опубликовано: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
по: Dean, G, и др.
Опубликовано: (2014)

MVA as a vector for vaccines against HIV-1.
по: Im, E, и др.
Опубликовано: (2004)

Engineering a dual vaccine against COVID-19 and tuberculosis
по: Carlyn Monèt Guthrie, и др.
Опубликовано: (2023-10-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
по: McShane, H
Опубликовано: (2020)

Local pulmonary immunological biomarkers in tuberculosis
по: Morrison, H, и др.
Опубликовано: (2021)

Local Pulmonary Immunological Biomarkers in Tuberculosis
по: Hazel Morrison, и др.
Опубликовано: (2021-03-01)

Tuberculosis vaccines in clinical trials.
по: Rowland, R, и др.
Опубликовано: (2011)